Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto B Santos

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|May 20, 2011
Radioiodine therapy for hyperthyroidismDanilo Villagelin, Roberto B Santos, João H Romaldini
Thyroid : Official Journal of the American Thyroid Association|August 17, 2004
Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' diseaseRoberto B Santos, João H Romaldini, Laura S Ward
Clinical Nuclear Medicine|February 8, 2012
A randomized controlled trial to evaluate the effectiveness of 2 regimens of fixed iodine (¹³¹I) doses for Graves disease treatmentRoberto B Santos, João H Romaldini, Laura S Ward
Archives of Endocrinology and Metabolism|May 25, 2021
The change in the clinical presentation of Graves' disease: a 30 years retrospective survey in an academic Brazilian tertiary centerWanesa Pinto, João H Romaldini, Nicolas Perini, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2015
Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole TreatmentDanilo Villagelin, João H Romaldini, Roberto B Santos, et al.
Clinical Endocrinology|November 6, 2007
Genetic polymorphisms associated with cigarette smoking and the risk of Graves' diseaseNatássia E Bufalo, Roberto B Santos, Adriano N Cury, et al.
American Journal of Medical Genetics. Part A|February 26, 2024
RET 634 germline/gonadal mosaicism generating a second pathogenic amino acid change in multiple endocrine neoplasia type 2AFlávia O F Valente, Cléber P Camacho, Susan C Lindsey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|May 20, 2011
Radioiodine therapy for hyperthyroidismDanilo Villagelin, Roberto B Santos, João H Romaldini
Thyroid : Official Journal of the American Thyroid Association|August 17, 2004
Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' diseaseRoberto B Santos, João H Romaldini, Laura S Ward
Clinical Nuclear Medicine|February 8, 2012
A randomized controlled trial to evaluate the effectiveness of 2 regimens of fixed iodine (¹³¹I) doses for Graves disease treatmentRoberto B Santos, João H Romaldini, Laura S Ward
Archives of Endocrinology and Metabolism|May 25, 2021
The change in the clinical presentation of Graves' disease: a 30 years retrospective survey in an academic Brazilian tertiary centerWanesa Pinto, João H Romaldini, Nicolas Perini, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2015
Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole TreatmentDanilo Villagelin, João H Romaldini, Roberto B Santos, et al.
Clinical Endocrinology|November 6, 2007
Genetic polymorphisms associated with cigarette smoking and the risk of Graves' diseaseNatássia E Bufalo, Roberto B Santos, Adriano N Cury, et al.
American Journal of Medical Genetics. Part A|February 26, 2024
RET 634 germline/gonadal mosaicism generating a second pathogenic amino acid change in multiple endocrine neoplasia type 2AFlávia O F Valente, Cléber P Camacho, Susan C Lindsey, et al.
Pageof 1